Avecho Biotechnology
Presence
Avecho Biotechnology is a company listed under the stock ticker AVE (AU).
Executives
View the org chart displaying its 6 main executives
Most searched biographies at Avecho Biotechnology
Popular executive movements at Avecho Biotechnology
- Kathy Connell has joined the company as Non-Executive Director (posted on April 29 2024).
Create your alert
to follow the executive moves at Avecho Biotechnology.
Pharmaceuticals
Avecho Biotechnology has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Avecho Biotechnology
- MEDIA | Channel 9 News - Avecho
- Avecho’s Phase III Clinical Trial for Insomnia Commences - Avecho
- Avecho completes meeting with TGA confirming pathway for Phase III Clinical Trial - Avecho
- Ethics Approval for amendments to Phase III Clinical Trial - Avecho
- Podcast: Money News with Scott Haywood - Avecho
- Placement to Advance Phase III Clinical Trial - Avecho
- Avecho reaches two-year stability milestone for its CBD softgel capsule - Avecho
- Avecho commences CBD softgel manufacturing for pivotal Phase III insomnia study - Avecho
- Media Centre - Avecho
- Avecho licenses TPM® for development of enhanced cancer drugs - Avecho
- View more press releases Close
Social media about Avecho Biotechnology
- Avecho Biotechnology on Wikipedia, Google News & Yahoo Finance
- Avecho Biotechnology on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Greg Collier 
Call Avecho Biotechnology at +61 39...
